HER2-positive Breast Cancer: Jocelyn’s Story

Expert oncologist Julie Fisher, MD, is joined by her patient Jocelyn Mueller, who shares her personal journey with HER2-positive breast cancer.

EP. 1: An Overview of HER2-positive Breast Cancer

October 22nd 2021

Julie Fisher, MD, gives a brief overview of HER2-positive breast cancer and the tests available for diagnosis.

EP. 2: Being Diagnosed With HER2-positive Breast Cancer

October 22nd 2021

Jocelyn Mueller, a patient with HER2-positive breast cancer, explains how she received her diagnosis.

EP. 3: HER2-positive Breast Cancer: Pre-operative Therapies

October 29th 2021

Dr. Julie Fisher, an expert oncologist, describes the range of treatment options for HER2-positive breast cancer in the pre-operative setting.

EP. 4: HER2-positive Breast Cancer: Post-Operative Therapies

October 29th 2021

Dr. Julie Fisher details the therapies used for HER2-positive breast cancer in the post-operative setting, including newly available treatment options, and reviews data supporting the choice of therapy for each patient.

EP. 5: Receiving Treatment for HER2-positive Breast Cancer: The Patient Experience

November 5th 2021

Jocelyn Mueller describes the preoperative treatments she has received for HER2-positive breast cancer, and the questions she had for her medical care team.

EP. 6: Assessing HER2-positive Breast Cancer Treatment Responses and Managing Side Effects

November 5th 2021

Julie Fisher, MD, explains how she assesses HER2-positive breast cancer patients for treatment response, what side-effects can occur and how they can be managed.

EP. 7: The Patient’s Perspective on how Treatment for HER2-positive Breast Cancer impacts Daily Life

November 12th 2021

Jocelyn Mueller details how chemotherapy treatments have affected her daily life and her decision to receive treatment through a port.

EP. 8: The Importance of Support Networks for HER2-positive Breast Cancer

November 12th 2021

Julie Fisher, M.D., has a conversation with patient Jocelyn Mueller about the importance of good support networks when living with HER2-positive breast cancer.

EP. 9: HER2-positive Breast Cancer and COVID-19

November 19th 2021

Patient Jocelyn Mueller and oncologist Julia Fisher, M.D., describe some of the adjustments that had to be made to Jocelyn’s treatment for HER2-positive breast cancer due to the COVID-19 pandemic.